HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


KERX: Keryx Biopharmaceuticals Inc - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
KERYX BIOPHARMACEUTICALS INC (NASD)
KERX 2.30 -0.05 (-2.13%) Vol.  631,239 16.00 CST

Nov 11, 2009 AEterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (KRX-0401) at 51st Annual Meeting of the American Society of Hematology
Nov 11, 2009 Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
Nov 10, 2009 Conference Calls Today: 3:25-3:40 P.M. EDT
Nov 09, 2009 Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results
Nov 09, 2009 AEterna Zentaris: Scientific Article Supports Perifosine's Development in Kidney Cancer
Nov 09, 2009 BiomedReports: News and FDA Updates for Ferro (NYSE:FOE), Boston Scientific (NYSE:BSX), Keryx (Nasdaq:KERX)
Nov 06, 2009 Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST
Nov 04, 2009 Keryx Biopharmaceuticals to Present at the Merriman Curhan Ford 6th Annual Investor Summit
Nov 03, 2009 AnalystChoice.com Provides Analytical Coverage on DPL, SOL, YHOO,KERX, JACK and HCBK
Nov 02, 2009 StockProfiler.US: Stock Watch: NASDAQ: NGSX & KERX
Oct 29, 2009 StockProfiler.US: Stock Watch: NASDAQ: NGSX & KERX
Oct 29, 2009 Keryx Biopharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference
Oct 26, 2009 Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
Oct 23, 2009 RidgewaterEquity.com Free Fundamental Sector & Market Research onKERX, YHOO, GMCR, AINV, FULT and ASBC
Oct 19, 2009 BUYINS.NET: SCI, WW, ARA, KERX, WMGI, ARLP Expected To Be Higher Leading Up To Next Earnings Releases
 
ZACKS COMMENTARY FOR KERX

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research